A M Gotto, P H Jones, L W Scott. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdolescentAdultChildChild, PreschoolCholesterol/metabolismCholestyramine Resin/therapeutic useChylomicrons/metabolismClofibrate/therapeutic useColestipol/therapeutic useCoronary Disease/etiologyDextrothyroxine/therapeutic useDietary Fats/administration & dosageGemfibrozilHumansHyperlipidemia, Familial Combined/diagnosisHyperlipidemia, Familial Combined/etiologyHyperlipidemia, Familial Combined/geneticsHyperlipidemias/complicationsHyperlipidemias/diagnosisHyperlipidemias/diet therapyHyperlipidemias/surgeryHyperlipidemias/therapyHyperlipoproteinemia Type I/diagnosisHyperlipoproteinemia Type I/geneticsHyperlipoproteinemia Type II/diagnosisHyperlipoproteinemia Type II/etiologyHyperlipoproteinemia Type II/geneticsHyperlipoproteinemia Type III/diagnosisHyperlipoproteinemia Type III/geneticsHyperlipoproteinemia Type IV/diagnosisHyperlipoproteinemia Type IV/etiologyHyperlipoproteinemia Type IV/geneticsHyperlipoproteinemia Type V/diagnosisHyperlipoproteinemia Type V/etiologyHyperlipoproteinemia Type V/geneticsLipoproteins/metabolismLipoproteins, LDL/metabolismNeomycin/therapeutic useNiacin/therapeutic usePentanoic Acids/therapeutic useProbucol/therapeutic useReceptors, LDL/metabolismTriglycerides/metabolism
Substances： See more » ChylomicronsDietary FatsLipoproteinsLipoproteins, LDLPentanoic AcidsReceptors, LDLTriglyceridesCholestyramine ResinNiacinDextrothyroxineCholesterolClofibrateNeomycinColestipolProbucolGemfibrozil
Year: 1986 PMID： 3519132 DOI： 10.1016/s0011-5029(86)80011-6
Source DB: PubMed Journal: Dis Mon ISSN： 0011-5029 Impact factor: 3.800